Return to Headlines

Boehringer Ingelheim Cares Foundation donates $50,000 to Gwinnett County Public Schools Foundation

The nonprofit Boehringer Ingelheim Cares Foundation (BI Cares) recently gave $50,000 to the Gwinnett County Public Schools Foundation to provide underserved students the technology they need to stay connected while learning virtually, and to provide them nourishment essential for academic success through its school-based food pantry program. The contribution came from the COVID-19 Relief Fund that BI Cares established in 2020 in response to the tremendous unmet need caused by the pandemic.

BI Cares is the independent, philanthropic arm of Boehringer Ingelheim USA Corporation. Boehringer Ingelheim employs about 600 people in Duluth, at the U.S. headquarters of Boehringer Ingelheim Animal Health, which makes medicine for pets, horses and livestock.

“Helping communities thrive is at the core of what we do, and we’re pleased to lend a hand in a place that so many Boehringer Ingelheim employees call home,” said Randolph Legg, a director of the Boehringer Ingelheim Cares Foundation and president of the company’s U.S. Animal Health business.

“We are proud to help Gwinnett County students access the technology they need to learn and grow,” Legg said. “Our culture of giving back strengthens our communities and creates a healthier tomorrow for us all.” 

 

About Gwinnett County Public Schools Foundation Fund, Inc.

Gwinnett County Public Schools (GCPS) Foundation Fund, Inc. is a nonprofit 501C3 charitable organization dedicated to enhancing and expanding the academic initiatives of Gwinnett County Public Schools. To learn more about programs and initiatives of the GCPS Foundation, call 678.301.7287 or visit, www.gcps-foundation.org

 

About Boehringer Ingelheim Cares Foundation

Boehringer Ingelheim Cares Foundation is a nonprofit organization with a mission to strengthen our communities by improving the health and well-being of people and animals through its major programs: 

  1. A Patient Assistance Program that makes our branded medicines available free of charge to uninsured and underinsured patients who meet certain eligibility criteria
  2. A Product Donation Program that donates Boehringer Ingelheim medicines to approved nonprofit partners who distribute the medicines around the world where there is tremendous unmet need
  3. A Strategic Community Investment Program that provides financial support to community-driven programs that improve access to human and animal healthcare, enhance STEM education and strengthen the human-animal bond with a focus on the underserved
  4. A signature Health Coach Program at select free clinics in Connecticut to equip patients who are committed to improve their health with the knowledge, skills and confidence to better manage high blood pressure, high cholesterol, diabetes and other chronic conditions

 

About Boehringer Ingelheim

Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of around $21.3 billion (19 billion euros). Our significant investment of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.

We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and is part of the Boehringer Ingelheim group of companies.  In addition, there are Boehringer Ingelheim Animal Health in Duluth, GA and Boehringer Ingelheim Fremont, Inc. in Fremont, CA.

Boehringer Ingelheim is committed to improving lives and strengthening our communities.  Please visit www.boehringer-ingelheim.us/csr to learn more about Corporate Social Responsibility initiatives.

For more information, please visit www.boehringer-ingelheim.us, or follow us on Twitter @BoehringerUS.